Most previous studies acknowledge that abnormal epigenetic alterations of TSGs (e.g., PTEN, 14-3-3σ, MLH1, HOXA11) contribute to endometrial carcinoma. The gene discussed is PTEN; the disease is endometrial carcinoma.